Antipsychotic-induced amenorrhea

References

• Abraham, S., Fraser, I., Gebski, V., Knight, C., Llewellyn-Jones, D., Mira, M., et al. (1985). Menstruation, menstrual protection and menstrual cycle problems. The knowledge, attitudes and practices of young Australian women. Medical Journal of Australia, 142, 247–251.
   PubMed Web of Science ®Google Scholar
• Ahuja, N., Moorhead, S., Lloyd, A.J., & Cole, A.J. (2008a). Antipsychotic-induced hyperprolactinemia and delusion of pregnancy. Psychosomatics, 49, 163–167.
   PubMed Web of Science ®Google Scholar
• Ahuja, N., Vasudev, K., & Lloyd, A. (2008b). Hyperprolactinemia and delusion of pregnancy. Psychopathology, 41, 65–68.
   PubMed Web of Science ®Google Scholar
• Andrist, L.C., Hoyt, A., Weinstein, D., & McGibbon, C. (2004). The need to bleed: women's attitudes and beliefs about menstrual suppression. Journal of the American Academy of Nurse Practitioners, 16, 31–37.
   PubMedGoogle Scholar
• Aubeny, A. (2007). Are monthly menstrual periods optional?: A European perspective. Reproductive Health Matters, 15, 183–185.
   PubMed Web of Science ®Google Scholar
• Aydin, Y., Atis, A., Kaleli, S., Uludağ, S., & Goker, N. (2010). Cabergoline versus bromocriptine for symptomatic treatment of premenstrual mastalgia: A randomised, open-label study. European Journal of Obstetrics and Gynecology, and Reproductive Biology, 150, 203–206.
   PubMed Web of Science ®Google Scholar
• Baltieri, D.A., & Guerra De Andrade, A. (2009). Schizophrenia modifying the expression of gender identity disorder. Journal of Sexual Medicine, 6, 1185–1188.
   PubMed Web of Science ®Google Scholar
• Beausang, C.C., & Razor, A.G. (2000). Young Western women's experiences of menarche and menstruation. Health Care for Women International, 21, 517–528.
   PubMedGoogle Scholar
• Beier, K.M., Wille, R., & Wessel, J. (2006). Denial of pregnancy as a reproductive dysfunction: A proposal for international classification systems. Journal of Psychosomatic Research, 61, 723–730.
   PubMed Web of Science ®Google Scholar
• Bergemann, N., Mundt, C., Parzer, P., Jannakos, I., Nagl, I., Salbach, B., et al. (2005). Plasma concentrations of estradiol in women suffering from schizophrenia treated with conventional versus atypical antipsychotics. Schizophrenia Research, 73, 357–366.
   PubMed Web of Science ®Google Scholar
• Berterö, C. (2003). What do women think about menopause? A qualitative study of women's expectations, apprehensions and knowledge about the climacteric period. International Nursing Review, 50, 109–118.
   PubMedGoogle Scholar
• Borras, L., Huguelet, P., & Eytan, A. (2007). Delusional “pseudotranssexualism” in schizophrenia. Psychiatry, 70, 175–179.
   PubMed Web of Science ®Google Scholar
• Bostwick, J.R., Guthrie, S.K., & Ellingrod, V.L. (2009). Antipsychotic-induced hyperprolactinemia. Pharmacotherapyz, 29, 64–73.
   PubMed Web of Science ®Google Scholar
• Boughton, M.A. (2002). Premature menopause: Multiple disruptions between the woman's biological body experience and her lived body. Journal of Advanced Nursing, 37, 423–430.
   PubMed Web of Science ®Google Scholar
• Britton, C. (1996). Learning about ‘the curse’: An anthropological perspective on experiences of menstruation. Women's Studies International Forum, 19, 645–653.
   Web of Science ®Google Scholar
• Brooke Medicine Eagle. (1991). Buffalo Woman Comes SingingNew YorkBallantine
   Google Scholar
• Davidson, S., Judd, F., Jolley, D., Hocking, B., Thompson, S., & Hyland, B. (2001). Risk factors for HIV/AIDS and hepatitis C among the chronic mentally ill. Australian & New Zealand Journal of Psychiatry, 35, 203–209.
   PubMed Web of Science ®Google Scholar
• Dubravko, H. (2010). Pseudocyesis in peri- and postmenopausal women. Central European Journal of Medicine, 5, 372–374.
   Google Scholar
• Edelman, A., Lew, R., Cwiak, C., Nichols, M., & Jensen, J. (2007). Acceptability of contraceptive-induced amenorrhea in a racially diverse group of US women. Contraception, 75, 450–453.
   PubMed Web of Science ®Google Scholar
• Elson, J. (2002). Menarche, menstruation, and gender identity: Retrospective accounts from women who have undergone premenopausal hysterectomy. Sex Roles, 46, 37–48.
   Web of Science ®Google Scholar
• Estanislau do Amaral, M.C., Hardy, E., Hebling, E.M., & Faundes, A. (2005). Menstruation and amenorrhea: Opinion of Brazilian women. Contraception, 72, 157–161.
   PubMed Web of Science ®Google Scholar
• Ghadirian, A.M., Chouinard, G., & Annable, L. (1982). Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients. Journal of Nervous and Mental Disease, 170, 463–467.
   PubMed Web of Science ®Google Scholar
• Haddad, P.M., & Sharma, S.G. (2007). Adverse effects of atypical antipsychotics: Differential risk and clinical implications. CNS Drugs, 21, 911–936.
   PubMed Web of Science ®Google Scholar
• Haddad, P.M., & Wieck, A. (2004). Antipsychotic-induced hyperprolactinaemia: Mechanisms, clinical features and management. Drugs, 64, 2291–2314.
   PubMed Web of Science ®Google Scholar
• Halbreich, U., & Kahn, L.S. (2003). Hyperprolactinemia and schizophrenia: Mechanisms and clinical aspects. Journal of Psychiatric Practice, 9, 344–353.
   PubMedGoogle Scholar
• Hummer, M., & Huber, J. (2004). Hyperprolactinaemia and antipsychotic therapy in schizophrenia. Current Medical Research Opinion, 20, 189–197.
   PubMed Web of Science ®Google Scholar
• Johnston-Robledo, I., Ball, M., Lauta, K., & Zekoll, A. (2003). To bleed or not to bleed: Young women's attitudes toward menstrual suppression. Women Health, 38, 59–75.
   PubMed Web of Science ®Google Scholar
• Kim, J., Kim, S., Kim, S., & Choi, S. (2010). Menstrual irregularities and sex hormones in female patients treated with conventional antipsychotics for more than 5 years. Clinical Psychopharmacology and Neuroscience, 8, 21–25.
   Google Scholar
• Kinon, B.J., Gilmore, J.A., Liu, H., & Halbreich, U.M. (2003). Hyperprolactinemia in response to antipsychotic drugs: Characterization across comparative clinical trials. Psychoneuroendocrinology, 28(Suppl 2), 69–82.
   PubMed Web of Science ®Google Scholar
• Kitzinger, C., & Willmott, J. (2002). ‘The thief of womanhood’: Women's experience of polycystic ovarian syndrome. Social Science & Medicine, 54, 349–361.
   PubMed Web of Science ®Google Scholar
• Knegtering, H., van der Moolen, A.E., Castelein, S., Kluiter, H., & van den Bosch, R.J. (2003). What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning? Psychoneuroendocrinology, 28(Suppl 2), 109–123.
   PubMed Web of Science ®Google Scholar
• Laursen, T.M., & Munk-Olsen T. (2010). Reproductive patterns in psychotic patients. Schizophrenia Research, 121, 234–240.
   PubMed Web of Science ®Google Scholar
• Lee, B.-H., Kim, Y.-K., & Park, S.-H. (2006). Using aripiprazole to resolve antipsychotic-induced symptomatic hyperprolactinemia: A pilot study. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 3, 714–717.
   Google Scholar
• Lee, M.S., Song, H.C., An, H., Yang, J., Ko, Y.H., Jung, I.K., et al. (2010). Effect of bromocriptine on antipsychotic drug-induced hyperprolactinemia: Eight-week randomized, single-blind, placebo-controlled, multicenter study. Psychiatry and Clinical Neuroscience, 64, 19–27.
   PubMed Web of Science ®Google Scholar
• Madhusoodanan, S., Parida, S., & Jimenez, C. (2010). Hyperprolactinemia associated with psychotropics – A review. Human Psychopharmacology, 25, 281–297.
   PubMed Web of Science ®Google Scholar
• Marván, M.L., Espinosa-Hernández, G., & Vacio, A. (2002). Premenarcheal Mexican girls' expectations concerning perimenstrual changes and menstrual attitudes. Journal of Psychosomatic Obstetrics and Gynaecology, 23, 89–96.
   PubMed Web of Science ®Google Scholar
• Marván, M.L., & Trujillo, P. (2010). Menstrual socialization, beliefs, and attitudes concerning menstruation in rural and urban Mexican women. Health Care for Women International, 31, 53–67.
   PubMed Web of Science ®Google Scholar
• Miller, K.K. (2004). Management of hyperprolactinemia in patients receiving antipsychotics. CNS Spectrum, 9(Suppl 7), 28–32.
   PubMed Web of Science ®Google Scholar
• Moloney, S. (2010). How menstrual shame affects birth. Women and Birth, 23, 153–159.
   PubMedGoogle Scholar
• Montejo, A.L. (2008). Prolactin awareness: An essential consideration for physical health in schizophrenia. European Neuropsychopharmacology, 18(Suppl 2), 108–114.
   PubMed Web of Science ®Google Scholar
• Montgomery, J., Winterbottom, E., Jessani, M., Kohegyi, E., Fulmer, J., Seamonds, B., et al. (2004). Prevalence of hyperprolactinemia in schizophrenia: Association with typical and atypical antipsychotic treatment. Journal of Clinical Psychiatry, 65, 1491–1498.
   PubMed Web of Science ®Google Scholar
• Morrison, L.A., Larkspur, L., Calibuso, M.J., & Brown, S. (2010). Women's attitudes about menstruation and associated health and behavioral characteristics. American Journal of Health Behavior, 34, 90–100.
   PubMed Web of Science ®Google Scholar
• Museum of Menstruation. Retrieved from http://www.mum.org/stopmen.htm.
   Google Scholar
• Ostler, T., & Kopels, S. (2010). Schizophrenia and filicide. Current Women's Health Reviews, 6, 58–62.
   Google Scholar
• Perkins, D.O. (1999). Adherence to antipsychotic medications. Journal of Clinical Psychiatry, 60, S25–S30.
   PubMed Web of Science ®Google Scholar
• Powell, A.D. (2001). The medication life. Journal of Psychotherapy Practice and Research, 10, 217–222.
   PubMedGoogle Scholar
• Roberts, T.A. (2004). Female trouble: The menstrual self-evaluation scale and women's self-objectification. Psychology of Women Quarterly, 28, 22–26.
   Web of Science ®Google Scholar
• Schooler, D., Ward, L.M., Merriwether, A., & Caruthers, A.S. (2005). Cycles of shame: Menstrual shame, body shame, and sexual decision-making. Journal of Sex Research, 42, 324–334.
   PubMed Web of Science ®Google Scholar
• Shah, A., & Christopherson, R. (2010). Prenatal care for women with schizophrenia. Current Women's Health Reviews, 6, 28–33.
   Google Scholar
• Smith, S., Wheeler, M.J., Murray, R., & O'Keane, V. (2002). The effects of antipsychotic-induced hyperprolactinaemia on the hypothalamic-pituitary-gonadal axis. Journal of Clinical Psychopharmacology, 22, 109–114.
   PubMed Web of Science ®Google Scholar
• Solari, H. (2010). Psychotic denial of pregnancy. Current Women's Health Reviews, 6, 22–27.
   Google Scholar
• Solari, H., Dickson, K.E., & Miller, L. (2009). Understanding and treating women with schizophrenia during pregnancy and postpartum. Canadian Journal of Clinical Pharmacology, 16, e23–e32.
   PubMedGoogle Scholar
• Spielvogel, A.M., & Hohener, H.C. (1995). Denial of pregnancy: A review and case reports. Birth, 22, 220–226.
   PubMed Web of Science ®Google Scholar
• Stubbs, M.L. (2008). Cultural perceptions and practices around menarche and adolescent menstruation in the United States. Annals of the New York Academy of Sciences, 1135, 58–66.
   PubMed Web of Science ®Google Scholar
• Takahashi, H., Higuchi, H., Kamata, M., Naitoh, S., Yoshida, K., Shimizu, T., et al. (2003). Effectiveness of switching to quetiapine for neuroleptic-induced amenorrhea. Journal of Neuropsychiatry and Clinical Neuroscience, 15, 375–377.
   PubMed Web of Science ®Google Scholar
• Torre, D.L., & Falorni, A. (2007). Pharmacological causes of hyperprolactinemia. Therapeutics & Clinical Risk Management, 3, 929–951.
   PubMedGoogle Scholar
• Umeora, O.U., & Egwuatu, V.E. (2008). Menstruation in rural Igbo women of south east Nigeria: Attitudes, beliefs and practices. African Journal of Reproductive Health, 12, 109–115.
   PubMedGoogle Scholar
• Urban, M. (2009). Transsexualism or delusions of sex change? Avoiding misdiagnosis. Psychiatria Polska, 43, 719–728.
   PubMed Web of Science ®Google Scholar
• Wieck, A., & Haddad, P. (2002). Hyperprolactinaemia caused by antipsychotic drugs. British Medical Journal, 324, 250–252.
   PubMed Web of Science ®Google Scholar
• Wieck, A., & Haddad, P.M. (2003). Antipsychotic-induced hyperprolactinaemia in women: Pathophysiology, severity and consequences. Selective literature review. British Journal of Psychiatry, 182, 199–204.
   PubMed Web of Science ®Google Scholar
• World Health Organization. (1999). How women perceive menstruation and their menstrual pattern. Progress in Reproductive Health Research, 52, 2–3.
   Google Scholar
• Yasui-Furukori, N., Saito, M., Nakagami, T., Sugawara, N., Sato, Y., Tsuchimine, S., et al. (2010). Gender-specific prolactin response to antipsychotic treatments with risperidone and olanzapine and its relationship to drug concentrations in patients with acutely exacerbated schizophrenia. Progress in Neuropsychopharmacology and Biological Psychiatry, 34, 537–540.
   PubMed Web of Science ®Google Scholar
• Zhang-Wong, J.H., & Seeman, M.V. (2002). Antipsychotic drugs, menstrual regularity and osteoporosis risk. Archives of Women's Mental Health, 5, 93–98.
   PubMedGoogle Scholar